<?xml version="1.0" encoding="UTF-8"?>
<ref id="B45-vaccines-08-00531">
 <label>45.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tlaxca</surname>
    <given-names>J.L.</given-names>
   </name>
   <name>
    <surname>Ellis</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Remmele</surname>
    <given-names>R.L.</given-names>
   </name>
  </person-group>
  <article-title>Live attenuated and inactivated viral vaccine formulation and nasal delivery: Potential and challenges</article-title>
  <source>Adv. Drug Deliv. Rev.</source>
  <year>2015</year>
  <volume>93</volume>
  <fpage>56</fpage>
  <lpage>78</lpage>
  <pub-id pub-id-type="doi">10.1016/j.addr.2014.10.002</pub-id>
  <pub-id pub-id-type="pmid">25312673</pub-id>
 </element-citation>
</ref>
